|
1
|
Hayes DF, Isaacs C and Stearns V:
Prognostic factors in breast cancer: current and new predictors of
metastasis. J Mammary Gland Biol Neoplasia. 6:375–392. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3
|
Korean Breast Cancer Society. Korean
breast cancer data of 1996. J Korean Surg Soc. 55:621–635.
1998.
|
|
4
|
Keen JC and Davidson NE: The biology of
breast carcinoma. Cancer. 97:825–833. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anandappa SY, Sibson R, Platt-Higgins A,
Winstanley JH, Rudland PS and Barraclough R: Variant estrogen
receptor α mRNAs in human breast cancer specimens. Int J Cancer.
88:209–216. 2000.
|
|
6
|
Mostert B, Sleijfer S, Foekens JA and
Gratama JW: Circulating tumor cells (CTCs): detection methods and
their clinical relevance in breast cancer. Cancer Treat Rev.
35:463–474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yugarani T, Tan BKH, The M and Das NP:
Effects of polyphenolic natural products on the lipid profiles of
rats fed high fat diets. Lipids. 27:181–186. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu TW, Zeng LH, Wu J and Fung KP: Morin: a
wood pigment that protects three types of human cells in the
cardiovascular system against oxyradical damage. Biochem Pharmacol.
47:1099–1103. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kleijnen J and Knipschild P: Ginkgo
biloba. Lancet. 340:1136–1139. 1992. View Article : Google Scholar
|
|
10
|
McGregor D: Diets, food components and
human cancer. Biotherapy. 11:189–200. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Robak J and Gryglewski RJ: Flavonoids are
scavengers of superoxide anion. Biochem Pharmacol. 37:83–88.
1998.
|
|
12
|
Husain SR, Cillard J and Cillard P:
Hydroxyl radical scavenging activity of flavonoids. Phytochemistry.
26:2489–2492. 1987. View Article : Google Scholar
|
|
13
|
Stavric B: Role of chemopreventers in
human diet. Clin Biochem. 27:319–332. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang LW, Juang LJ, Wang BS, Wang MY, Tai
HM, Hung WJ, Chen YJ and Huang MH: Antioxidant and antityrosinase
activity of mulberry (Morus alba L.) twigs and root bark.
Food Chem Toxicol. 49:785–790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ramanathan L, Das NP and Li QT: Studies on
lipid oxidation in fish phospholipid liposomes. Biol Trace Elem
Res. 40:59–70. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanasaki Y, Ogawaa S and Fukui S: The
correlation between active oxygens scavenging and antioxidative
effects of flavonoids. Free Radic Biol Med. 16:845–850. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakadate T, Yamamoto S, Aizu E and Kato R:
Effects of flavonoids and antioxidants on
12-O-tetradecanoylphorbol-13-acetate-caused epidermal ornithine
decarboxylase induction and tumor promotion in relation to
lipoxygenase inhibition by these compounds. Gann. 75:214–222.
1984.
|
|
18
|
Baumann J, Bruchhausen FV and Wurm G:
Flavonoids and related compounds as inhibitors of arachidonic acid
peroxidation. Prostaglandins. 20:627–639. 1980. View Article : Google Scholar
|
|
19
|
Francis AR, Shetty TK and Bhattacharya RK:
Modulating effect of plant flavonoids on the mutagenicity of
N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 10:1953–1955.
1989.PubMed/NCBI
|
|
20
|
Huang MT, Wood AW, Newmark HL, Sayer JM,
Yagi H, Jerina DM and Conney AH: Inhibition of the mutagenicity of
bay-region diol-epoxides of polycyclic aromatic hydrocarbons by
phenolic plant flavonoids. Carcinogenesis. 4:1631–1637. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Denda A, Ura H, Tsujiuchi T, Tsutsumi M,
Eimoto H, Takashima Y, Kitazawa S, Kinugasa T and Konishi Y:
Possible involvement of arachidonic acid metabolism in
phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis.
10:1929–1935. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin H, Lee WS, Yun JW, Jung JH, Lee SM,
Kim HJ, Choi YH, Kim GS, Jung JM, Ryu CH, Shin SC and Hong SC:
Flavonoids from Citrus unshiu Marc. inhibit cancer cell
adhesion to endothelial cells by selective inhibition of VCAM-1.
Oncol Rep. 30:2336–2342. 2013.
|
|
23
|
Vihinen P and Kahari VM: Matrix
metalloproteinases in cancer: prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
25
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lelongt B, Trugnan G, Murphy G and Ronco
PM: Matrix metalloproteinases MMP2 and MMP9 are produced in early
stages of kidney morphogenesis but only MMP9 is required for renal
organogenesis in vitro. J Cell Biol. 136:1363–1373. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sarén P, Welgus HG and Kovanen PT:
TNF-alpha and IL-1beta selectively induce expression of 92-kDa
gelatinase by human macrophages. J Immunol. 157:4159–4165.
1996.PubMed/NCBI
|
|
28
|
Przybylowska K, Kluczna A, Zadrozny M,
Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski
J and Blasiak J: Polymorphisms of the promoter regions of matrix
metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast
Cancer Res Treat. 95:65–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Steeg PS: Cancer: micromanagement of
metastasis. Nature. 449:671–673. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Steeg PS: Tumor metastasis: mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eccles SA and Welch DR: Metastasis: recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
White ES, Strom SR, Wys NL and Arenberg
DA: Non-small cell lung cancer cells induce monocytes to increase
expression of angiogenic activity. J Immunol. 166:7549–7555. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ueno T, Toi M, Saji H, Muta M, Bando H,
Kuroi K, Koike M, Inadera H and Matsushima K: Significance
macrophage chemoattractant protein-1 in macrophage recruitment,
angiogenesis, and survival in human breast cancer. Clin Cancer Res.
6:3282–3289. 2000.PubMed/NCBI
|
|
34
|
Naylor MS, Stamp GW, Davies BD and
Balkwill FR: Expression and activity of MMPS and their regulators
in ovarian cancer. Int J Cancer. 58:50–56. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD,
Yang F and Xu XC: Prognostic significance of MMP-9 and TIMP-1 serum
and tissue expression in breast cancer. Int J Cancer.
122:2050–2056. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suyama K, Shapiro I, Guttman M and Hazan
RB: A signaling pathway leading to metastasis is controlled by
N-cadherin and the FGF receptor. Cancer Cell. 2:301–314. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hulit J, Suyama K, Chung S, Keren R,
Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K
and Hazan RB: N-cadherin signaling potentiates mammary tumor
metastasis via enhanced extracellular signal-regulated kinase
activation. Cancer Res. 67:3106–3116. 2007. View Article : Google Scholar
|
|
39
|
Nagi C, Guttman M, Jaffer S, Qiao R, Keren
R, Triana A, Li M, Godbold J, Bleiweiss IJ and Hazan RB: N-cadherin
expression in breast cancer: correlation with an aggressive
histologic variant--invasive micropapillary carcinoma. Breast
Cancer Res Treat. 94:225–235. 2005. View Article : Google Scholar
|
|
40
|
Walsh MM and Bleiweiss IJ: Invasive
micropapillary carcinoma of the breast: eighty cases of an
underrecognized entity. Hum Pathol. 32:583–589. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ho AT, Voura EB, Soloway PD, Watson KL and
Khokha R: MMP inhibitors augment fibroblast adhesion through
stabilization of focal adhesion contacts and up-regulation of
cadherin function. J Biol Chem. 276:40215–40224. 2001. View Article : Google Scholar
|
|
42
|
Covington MD, Burghardt RC and Parrish AR:
Ischemia-induced cleavage of cadherins in NRK cells requires
MT1-MMP (MMP-14). Am J Physiol Renal Physiol. 290:F43–F51. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pon YL, Auersperg N and Wong AS:
Gonadotropins regulate N-cadherin mediated human ovarian surface
epithelial cell survival at both posttranslational and
transcriptional levels through a cyclic AMP/protein kinase A
pathway. J Biol Chem. 280:15438–15448. 2005. View Article : Google Scholar
|
|
44
|
Yoon SO, Shin S, Lee HJ, Chun HK and Chung
AS: Isoginkgetin inhibits tumor cell invasion by regulating
phosphatidylinositol 3-kinase/Akt-dependent matrix
metalloproteinase-9 expression. Mol Cancer Ther. 5:2666–2675. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chung TW, Lee YC and Kim CH: Hepatitis B
viral HBx induces matrix metallo-proteinase-9 gene expression
through activation of ERK and PI-3K/AKT pathways: involvement of
invasive potential. FASEB J. 18:1123–1125. 2004.PubMed/NCBI
|
